Compare
5 stocks, side by sideRelative performance · rebased to 100
CRNXTLXNAMSRCUSELVN
| CRNXCrinetics Pharmaceuticals, Inc. | TLXTelix Pharmaceuticals Limited | NAMSNewAmsterdam Pharma Company N.V. | RCUSArcus Biosciences, Inc. | ELVNEnliven Therapeutics, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 4/10 | - | 3/10 | 8/10 | 10/10 |
| Price | $34.99 | $10.86 | $31.73 | $30.25 | $49.12 |
| 1 month | -4.9% | +13% | -12% | +25% | +15% |
| 1 year | +13% | -34% | +72% | +246% | +132% |
| 5 year | +81% | - | +225% | +27% | +61% |
| P/E (TTM) | -7.4 | - | -17.4 | -10.3 | -35.5 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $3.7B | $3.7B | $3.7B | $3.8B | $3.5B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.